StockData
Mangoceuticals, Inc. logo

Mangoceuticals, Inc. (MGRX) income statement

MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$0.15−0.01 (-8.44%)

Close on Nov 18, 2026Market cap $3.16MP/E –Yield –

Mangoceuticals, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
54.4%
Operating margin
-3829.0%
Net margin
-4791.3%
Return on equity, FY2025
-141.6%

Financial strength

Current ratio
0.18
Debt to equity
–
Debt to assets
–
Cash to current liabilities
16.4%

Valuation

P/E ratio
–
Price to sales
10.02
Price to book
0.25
Dividend yield
–

See a number that looks wrong?